V · Healthcare

CanadaBis Capital Inc (CANB)

Drug Manufacturers - Specialty & Generic

CanadaBis Capital Inc (CANB) is listed on V in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-05-23, reported P/E ratio is 18.00. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.

Download on the App Store Get it on Google Play

Key metrics for CANB

P/E ratio

18.00

CanadaBis Capital Inc (CANB) — FAQ

What is CANB's P/E ratio?

The price-to-earnings (P/E) ratio for CanadaBis Capital Inc (CANB) is 18.00 (data as of 2026-05-23).

Does CanadaBis Capital Inc pay a dividend?

Dividend yield is not available in the current snapshot for CanadaBis Capital Inc (CANB). Check the MyAverix Finance app for the latest dividend data.

What sector is CanadaBis Capital Inc in?

CanadaBis Capital Inc (CANB) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).

What exchange is CANB listed on?

CANB is listed on V.

Full report in the app

Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.

Related Healthcare companies

Abbott Laboratories (ABT) AbbVie Inc. CDR (ABBV) Agilent Technologies Inc. (A1GI34) Aimed Bio (0009K0) Alnylam Pharmaceuticals, Inc. (A1LN34) Alvotech (ALVO) Amgen Inc (AMGN34) argenx SE (A1RG34)